PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Experts Probe Economic Factors Driving Drug Shortages

Q&A: Rajiv Malik, President, Mylan

Keeping Up with Compliance in Labeling

Advertisement
Advertisement
Top Story
Pharma Companies and Patient Advocates Demand Protection for Part D "Protected Classes"
Trump administration proposals to revamp drug coverage and reimbursement policies governing Medicare Part D drug plans has generated loud objections from both manufacturers and patient advocates, writes Jill Wechsler.
/Read more/
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Pricing
Reacting to Reference Pricing
The industry should take a twin-track approach to the potential threat of the Trump administration's proposed move to reference pricing, writes Todd Edgar /Read more/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Learn more
Biotech
Trust–Biotech's Hidden Advantage
Bruce Hayes discusses how companies can build trust now to cultivate corporate reputations that build business
/Read more/
Advertisement
Pharmaceutical Executive: Emerging Pharma Leaders
Meet these winners who are vital to the future of the industry
Read the article
ADVERTISEMENT Advertisement
Calendar
/ December 12: Specialty Product Data Strategies /
Philadelphia, PA
/ January 22–23, 2019: 14th Biosimilars Summit /
Alexandria, VA
/ January 23–24, 2019: Data Analytics and Decisions /
Philadelphia, PA
/ January 24–25, 2019: Specialty Therapies 2019 /
Las Vegas, NV
/ January 29–30, 2019: 6th Annual Clinical Data Disclosure and Transparency /
Philadelphia, PA
/ February 4–5, 2019: Disease Awareness Campaigns /
Philadelphia, PA
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019 /
Baltimore, MD
Advertisement
Marketing
Being More Human Doesn't Mean Being Less Transparent
Like Facebook, many healthcare companies are trying to become more "like people". They should instead prioritize transparency and engaging in knowledge-sharing with the public, writes Julia Stern
/Read More/
Advertisement
Patient Assistance Centers of Excellence: The Next Generation of Brand Support
On Demand
Learn More
Audio
The Pharm Exec Podcast: Southeast Biotech
Jack Bailey, President of US Pharmaceuticals for GlaxoSmithKline, talks with Christen Harm and Michelle Maskaly about the biopharma landscape in the southeastern part of the United States, looking particularly at how North Carolina is growing, attracting, and retaining life science startups
/Read More/

Industry update
// Altimmune (Gaithersburg, MD), appointed Vipin K. Garg, Ph.D., as President and Chief Executive Officer, succeeding Bill Enright. // CURE Pharmaceutical (Oxnard, CA) hired Alex Katz as its new Chief Financial Officer. // NexImmune (Gaithersburg, MD) hired Naimish Pandya, M.D., as Vice President & Head of Clinical Development. and Alex Matschiner as Vice President of Protein Process Development. // Nkarta Therapeutics (South San Francisco, CA) named Kanya Rajangam, M.D., Ph.D., as Senior Vice President and Chief Medical Officer. // Patrick H. Griffin, M.D., F.A.C.P., joined Innovate Biopharmaceuticals (Raleigh, NC) as acting Head of Clinical Development.
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com